Quick Answer
Fulgent Genetics, Inc. reported Total Revenue of $322.67 million for the year ending 2025.
- Fulgent Genetics, Inc. showed an increase of +13.8% in Total Revenue from 2024 to 2025.
- This data is from Fulgent Genetics, Inc.'s annual report (Form 10-K), filed with the SEC on February 27, 2026.
- XBRL data for this metric is available from 2014 to 2025 (13 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2015: $1.59 million | Q2 2015: $2.18 million | Q3 2015: $2.91 million | Q4 2015: $2.90 million | Q1 2016: $3.44 million | Q2 2016: $3.97 million | Q3 2016: $5.01 million | Q4 2016: $5.85 million | Q1 2017: $5.31 million | Q1 2017: $5.31 million | Q2 2017: $4.64 million | Q2 2017: $4.64 million | Q3 2017: $4.50 million | Q3 2017: $4.50 million | Q4 2017: $4.28 million | Q4 2017: $4.28 million | Q1 2018: $4.65 million | Q1 2018: $4.65 million | Q2 2018: $5.40 million | Q2 2018: $5.40 million | Q3 2018: $5.63 million | Q3 2018: $5.63 million | Q4 2018: $5.67 million | Q1 2019: $5.37 million | Q2 2019: $8.42 million | Q3 2019: $10.35 million | Q4 2019: $8.39 million | Q1 2020: $7.75 million | Q2 2020: $17.27 million | Q3 2020: $101.72 million | Q4 2020: $294.98 million | Q1 2021: $359.43 million | Q2 2021: $153.62 million | Q3 2021: $227.87 million | Q4 2021: $251.67 million | Q1 2022: $320.27 million | Q2 2022: $125.34 million | Q3 2022: $105.66 million | Q4 2022: $67.70 million | Q1 2023: $66.17 million | Q2 2023: $67.85 million | Q3 2023: $84.69 million | Q1 2024: $64.49 million | Q2 2024: $71.03 million | Q3 2024: $71.74 million | Q1 2025: $73.46 million | Q2 2025: $81.80 million | Q3 2025: $84.07 million.
- Over the full 13 years of available data (2014 to 2025), Fulgent Genetics, Inc.'s Total Revenue has grown by 25,148.1%.
- Historical annual values: Fiscal year 2025: $322.67 million | Fiscal year 2024: $283.47 million | Fiscal year 2023: $289.21 million | Fiscal year 2022: $618.97 million | Fiscal year 2021: $992.58 million | Fiscal year 2020: $421.71 million | Fiscal year 2019: $32.53 million | Fiscal year 2018: $21.35 million | Fiscal year 2017: $18.73 million | Fiscal year 2017: $18.73 million | Fiscal year 2016: $18.28 million | Fiscal year 2015: $9.58 million | Fiscal year 2014: $1.28 million.
- Data sourced from SEC EDGAR public filings as of August 8, 2026.
Last verified: